Literature DB >> 16120706

Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents.

Erika Samoff1, Emilia H Koumans, Lauri E Markowitz, Maya Sternberg, Mary K Sawyer, David Swan, John R Papp, Carolyn M Black, Elizabeth R Unger.   

Abstract

Human papillomavirus (HPV) infection is a necessary but not sufficient cause of cervical cancer. While chlamydia infection has been associated with cervical cancer, the meaning of this association remains unclear. The authors' objective was to investigate this association by evaluating whether concurrent genital tract infections are associated with HPV persistence, a precursor to cervical cancer. Interview data and biologic samples for HPV, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and bacterial vaginosis testing were collected from female adolescents in an Atlanta, Georgia, longitudinal cohort study at 6-month visits (1999-2003). Associations with persistence (detection of the same HPV type at two sequential visits (visit pair)) were assessed among subjects with 2-5 visits and > or =6 months of follow-up. Associations were evaluated by logistic regression using methods for correlated data. Type-specific persistence of high-risk HPV types was detected in 77 of 181 (43%) analyzed visit pairs. Concurrent infection with C. trachomatis was independently associated with persistence of high-risk HPV types (adjusted odds ratio = 2.1, 95% confidence interval: 1.0, 4.1). Infection with more than one HPV type at the initial visit was also associated with high-risk persistence (adjusted odds ratio = 2.8, 95% confidence interval: 1.6, 4.9). The association between chlamydia infection and cervical cancer may be due to an effect of chlamydia infection on persistence of high-risk HPV.

Entities:  

Mesh:

Year:  2005        PMID: 16120706     DOI: 10.1093/aje/kwi262

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  60 in total

1.  Distribution of Chlamydia trachomatis serotypes in clinical urogenital samples from north-eastern Croatia.

Authors:  Zinka Bošnjak; Snježana Džijan; Dinko Pavlinić; Magdalena Perić; Nataša Ružman; Ivana Roksandić Križan; Gordan Lauc; Arlen Antolović-Požgain; Jelena Burazin; Dubravka Vuković
Journal:  Curr Microbiol       Date:  2012-03-11       Impact factor: 2.188

2.  The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.

Authors:  Ying Peng; Lei Zhao; Sudhanshu Shekhar; Lu Liu; Hong Wang; Qiang Chen; Xiaoling Gao; Xi Yang; Weiming Zhao
Journal:  Cell Mol Immunol       Date:  2012-06-25       Impact factor: 11.530

Review 3.  Conservative management of adolescents with abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  J Natl Compr Canc Netw       Date:  2008-01       Impact factor: 11.908

4.  The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.

Authors:  Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith
Journal:  Sex Transm Dis       Date:  2015-06       Impact factor: 2.830

5.  Prevalence of sexually transmitted infections in at-risk adolescent females at a comprehensive, stand-alone adolescent health center in New York City.

Authors:  Risa L Yavorsky; Dominic Hollman; John Steever; Christine Soghomonian; Angela Diaz; Howard Strickler; Nicolas Schlecht; Robert D Burk; Christopher N Ochner
Journal:  Clin Pediatr (Phila)       Date:  2014-05-07       Impact factor: 1.168

6.  Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytology.

Authors:  Donatella Panatto; Daniela Amicizia; Silvia Bianchi; Elena Rosanna Frati; Carla Maria Zotti; Piero Luigi Lai; Alexander Domnich; Daniela Colzani; Roberto Gasparini; Elisabetta Tanzi
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway.

Authors:  Kirsten A Johnson; Ming Tan; Christine Sütterlin
Journal:  Cell Microbiol       Date:  2009-03-12       Impact factor: 3.715

8.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

9.  Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.

Authors:  Anja Weinreich Olsen; Michael Theisen; Dennis Christensen; Frank Follmann; Peter Andersen
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

10.  Human Papillomaviruses and genital co-infections in gynaecological outpatients.

Authors:  Rosita Verteramo; Alessandra Pierangeli; Emanuela Mancini; Ettore Calzolari; Mauro Bucci; John Osborn; Rosa Nicosia; Fernanda Chiarini; Guido Antonelli; Anna Marta Degener
Journal:  BMC Infect Dis       Date:  2009-02-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.